This is interesting from a couple of yrs ago. ENTB Peer reviewed published paper on COPD. Funding seems to have been the issue here and now that they have it can move the progress forward. They have multiple therapies.
Entest BioMedical Publishes Journal Article on Laser Activation of Stem Cells for Treatment of Chronic Obstructive Pulmonary Disease (COPD)Details of Regenerative Photoceutical Approach Disclosed in Peer-Reviewed Paper. They have multiple therapies.
Entest BioMedical Inc. (OTCBB: ENTB) announced publication of its manuscript "Lasers, Stem Cells, and COPD" in the peer-reviewed Journal ofTranslational Medicine. The manuscript was a collaborative effort led by Entest that included researchers from the University of California San Diego, University of Utah, the Center for the Study of Natural Oncology, and Cromos Pharma Services. The paper may be freely accessed at: http://www.translational-medicine.com/.
"Entest's Regenerative Photoceutical approach as represented by our ENT-576™ program offers the possibility of using laser light to direct stem cell homing and activation. To our knowledge this is the first description in the peer reviewed arena of treating COPD via this method,"
News 
Market Data 
Discover 
